Selank and Semax: The Nootropic Peptides You Haven't Heard Of

The Russian Peptide Research Tradition

Russia has a long, distinct tradition of peptide pharmacology that doesn't get enough recognition in Western research circles. The Institute of Molecular Genetics and the Institute of Pharmacology at the Russian Academy of Sciences have been developing regulatory peptides since the 1980s, producing compounds like epithalon, selank, and semax that are prescribed clinically in Russia but remain largely unknown in the West.

Part of this is a language barrier — much of the early research was published exclusively in Russian journals. Part of it is regulatory: these peptides were developed outside the FDA framework and were never submitted for approval in Western markets. But the research itself is methodologically sound, often involving proper randomized controlled trials with hundreds of participants.

Selank and semax are two of the standout compounds from this tradition, and both target the brain in interesting ways.

Selank: The Anxiolytic

Selank is a synthetic analog of the naturally occurring immunomodulatory peptide tuftsin. It was developed at the Institute of Molecular Genetics in Moscow and approved for clinical use in Russia for generalized anxiety disorder in 2009.

What makes selank interesting isn't that it reduces anxiety — benzodiazepines do that too. It's how it reduces anxiety.

Mechanism

Selank modulates the GABA system — the same system benzodiazepines target — but without directly binding GABA receptors. Instead, it appears to influence the expression of GABA receptor subunits and the availability of GABA in the synaptic cleft. It also modulates serotonin metabolism, affecting the balance between serotonin and its metabolite 5-HIAA.

The result: anxiolytic effects comparable to low-dose benzodiazepines in clinical studies, but without the sedation, cognitive impairment, or dependence risk. You stay sharp. You just worry less.

Clinical data

Russian clinical trials with selank for generalized anxiety disorder showed significant reductions in anxiety scores (Hamilton Anxiety Rating Scale) compared to placebo. The effect onset was within days, and discontinuation didn't produce withdrawal symptoms — a stark contrast to benzodiazepine cessation.

Additional research suggests effects on cognitive function, particularly under stress. Selank appears to stabilize cognitive performance in conditions that normally cause deterioration (sleep deprivation, acute stress, information overload).

Semax: The Cognitive Enhancer

Semax is a synthetic analog of ACTH (adrenocorticotropic hormone), specifically a modified fragment of ACTH 4-10. It was developed at the same institute as selank and is approved in Russia as a nootropic and neuroprotective agent.

Mechanism

Semax acts on melanocortin receptors (MC3 and MC4) in the brain, but its most notable effect is on brain-derived neurotrophic factor (BDNF). A single intranasal dose of semax can increase BDNF levels by 200-400% in animal studies. BDNF is critical for neuronal survival, synaptic plasticity, learning, and memory formation.

It also increases nerve growth factor (NGF) and modulates dopaminergic and serotonergic neurotransmission. The overall profile is pro-cognitive and neuroprotective.

Clinical applications in Russia

Semax is prescribed in Russia for a remarkable range of neurological conditions: stroke recovery, traumatic brain injury, cognitive disorders, ADHD in children, and optic nerve disease. The breadth of approved indications reflects the fundamental nature of the BDNF pathway it targets.

For researchers interested in cognitive enhancement, the relevant data shows improved memory consolidation, faster information processing, and enhanced attention — particularly under demanding conditions. Unlike stimulants, semax doesn't produce jitteriness or a crash.

The BDNF Connection

BDNF deserves a closer look because it's one of the most important molecules in brain health, and both of these peptides influence it.

Brain-derived neurotrophic factor is a protein that supports existing neurons and encourages the growth of new ones. Think of it as fertilizer for your brain. Low BDNF levels are associated with depression, Alzheimer's disease, and cognitive decline. High BDNF levels are associated with better learning, memory, and mood.

Exercise is the most well-validated natural BDNF booster. Semax appears to be one of the most potent pharmacological ones. The magnitudes are comparable — a challenging workout can increase BDNF by 200-300%, and semax achieves similar or greater increases.

Selank's influence on BDNF is more modest but still documented. The two peptides may have complementary effects on neuroplasticity when used together.

Selank vs Semax

Many researchers run both: selank for anxiety and emotional regulation, semax for cognitive sharpness. The combination is well-documented in Russian clinical practice and the mechanisms don't overlap.

Practical Use

Both selank and semax are typically administered intranasally as nasal drops or sprays. This is unusual for research peptides — most are injected subcutaneously. The intranasal route works here because the nasal mucosa provides direct access to the brain through the olfactory nerve pathway, bypassing the blood-brain barrier.

• Selank: Common research doses are 250-500 mcg intranasally, 1-3 times daily. Cycles of 2-4 weeks are typical, with breaks in between.
• Semax: Common research doses are 200-600 mcg intranasally, 1-2 times daily. The N-acetyl semax (NASA) variant includes an additional amidate modification for enhanced stability and potency.
• Reconstitution: Both use BAC water. For intranasal delivery, the reconstituted solution is drawn into a nasal spray bottle or applied with a dropper.